An overall potential downregulation of the RAS was reported by Henry and colleagues [65], who observed decreased AngI and Ang1-7 in COVID-19 patients upon hospital admission compared to healthy controls, even though the enzymatic activity and concentration of ACE were not significantly different, and the activity and concentration of ACE2 were not determined [65]. This evidence concerns the gene ACE2 and COVID-19.